Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Cash $ 2,125,656   $ 3,027,033
Stock options 2,410,000 111,111  
Depreciation expense $ 9,681 $ 26  
Deferred rental income $ 7,254   12,769
Useful Life of patents and other technologies 5 years    
Impairment loss (1,321,338)
Intangible assets acquired     1,583,260
Due to related parties 450,000   $ 450,000
Shipping and Handling Costs $ 25 0  
Reverse split ratio 1:4    
Beijing GenExosome | Dr. Yu Zhou      
Equity interests ownership percentage     40.00%
Real property operating [Member]      
Depreciation expense $ 31,805 $ 0  
PRC [Member]      
Cash 1,251,993   $ 1,327,009
United States [Member]      
Cash $ 873,663   $ 1,700,024